In this CDER Conversation, Dr. Robert Ball, Deputy Director, Office of Surveillance & Epidemiology, explains the Emerging Drug Safety Technology Meeting (EDSTM) program and the application of artificial intelligence (AI) in pharmacovigilance: https://lnkd.in/eRg7K7GB
Way to go! This is real progress. Congratulations!
Looking forward to your talk Bob! Much needed🤖
Insightful!
Public Health Leader | Program Manager (Vaccine Academy) | Managing Partner, Pharmamed Spectrum Care (Shea Butter Skincare) | Pharmacist | Healthcare Mentor (PIH, IPSF-AfRO) | Ex- USAID/USP Consultant | MBA (LBS)
1wIt's interesting to see this highlights the critical role of innovation in safeguarding public health. Collaboration between regulators and industry leaders creates an optimal pathway and ensures patients have access to safe and effective medicines.